RUA Life Sciences has provided a trading statement for the year ending March 2021. Through the year the group achieved its objectives including the integration of RUA Medical, lead product development ahead of expected submission in June 21 and proof of concept accomplished on the polymeric heart valve. Revenues for the year are expected to be in line with our forecast of £1.4m and the group closed the year with cash of £6.4m, ahead of our £5.2m expectation. We believe RUA Life Sciences is in a ....
10 May 2021
Cenkos: RUA Life Sciences Plc -- Objectives achieved
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: RUA Life Sciences Plc -- Objectives achieved
RUA Life Sciences Plc (RUA:LON) | 10.2 0 0.0% | Mkt Cap: 6.36m
- Published:
10 May 2021 -
Author:
Chris Donnellan -
Pages:
5
RUA Life Sciences has provided a trading statement for the year ending March 2021. Through the year the group achieved its objectives including the integration of RUA Medical, lead product development ahead of expected submission in June 21 and proof of concept accomplished on the polymeric heart valve. Revenues for the year are expected to be in line with our forecast of £1.4m and the group closed the year with cash of £6.4m, ahead of our £5.2m expectation. We believe RUA Life Sciences is in a ....